Portfolio News

A potential game changer for student loan debt: The Employer Participation in Repayment Act

Written by Laurel Taylor, CEO and Founder of FutureFuel.io. The $900 billion Coronavirus Relief package is slated to bring much needed financial relief to Americans devastated by the COVID-19 pandemic. Within the relief package there is a transformative provision that will have far-reaching implications for the tens of millions of Americans burdened by student debt. It has the potential to slash the total student debt burden by one-third over the next decade. Read more >>
Read more...

ZetrOZ Systems Announces Expansion of Sustained Acoustic Medicine (SAM) Continuing Medical Education Courses

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device and global leader in the development of SAM technology, announces the expansion of the nationally recognized continuing medical education program, designed to train, and certify professionals including nurses, athletic trainers, physicians and physical therapists on the use and application of SAM technology. Courses will be led through a SAM Learning Management System virtually by Dr. Rod Walters and Dr. Rajiv Mallipudi, who will...
Read more...

Myomo Reports Preliminary Fourth Quarter and Full Year 2020 Results

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced preliminary financial and operational results for the fourth quarter and fiscal year ended December 31, 2020. In particular, Myomo expects revenue for the three months ended December 31, 2020 to more than double compared with the fourth quarter ended December 31, 2019, and also expects quarterly cash utilization to be the lowest since it became a publicly traded...
Read more...

Myomo to Present H.C. Wainwright Virtual BioConnect 2021 Conference

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, the Company’s chief executive officer, and David Henry, chief financial officer, will present at the H.C. Wainwright Virtual BioConnect 2021 Conference being held January 11-14, 2021. Read more >>
Read more...